Previous studies have established a connection between kalirin variants and susceptibility to schizophrenia, Alzheimer disease, adult attention deficit hyperactivity disorder (ADHD), coronary artery disease and ischemic stroke [29-34]. This evidence concerns the gene KALRN and Alzheimer disease.